Generation Bio DEF 14A: Executive Compensation Details
| Field | Detail |
|---|---|
| Company | Generation Bio Co. |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Gen Bio's proxy statement is out, detailing exec pay and stock awards for 2024. Check it for compensation insights.
AI Summary
Generation Bio Co. filed a DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and equity awards granted to its principal executive officers (PEO) and non-PEO named executive officers. It includes information on the year-end fair value of outstanding and unvested equity awards, as well as changes in fair value for awards granted in prior years.
Why It Matters
This filing provides transparency into how Generation Bio compensates its top executives, which can influence investor decisions and perceptions of the company's financial health and management strategy.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not inherently present new financial risks.
Key Numbers
- 2023 — Fiscal Year (Reporting period for prior year compensation data)
- 2022 — Fiscal Year (Reporting period for prior year compensation data)
- 2021 — Fiscal Year (Reporting period for prior year compensation data)
- 2020 — Fiscal Year (Reporting period for prior year compensation data)
Key Players & Entities
- Generation Bio Co. (company) — Filer of the DEF 14A
- 0001733294 (company) — Central Index Key for Generation Bio Co.
- 20250423 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for which compensation is reported
FAQ
What is the total reported compensation for the Principal Executive Officer (PEO) in 2024?
The filing indicates data points for PEO compensation for the 2024 fiscal year, including year-end fair value of equity awards and changes in fair value, but specific dollar amounts for total compensation are not detailed in the provided excerpt.
What types of equity awards are detailed in the filing for 2024?
The filing details 'Year End Free Value of Equity Awards Granted in Covered Year Outstanding and Unvested' and 'Change in Free Value of Outstanding and Unvested Equity Awards Granted in Prior Years' for both PEO and Non-PEO members for the 2024 fiscal year.
When was Generation Bio Co. incorporated?
Generation Bio Co. was incorporated in Delaware (DE).
What is the business address of Generation Bio Co.?
The business address is 301 BINNEY STREET, CAMBRIDGE, MA 02142.
What is the SIC code for Generation Bio Co.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Generation Bio Co..